116O Palbociclib (PAL) plus letrozole (L) as first-line (1L) therapy (tx) in postmenopausal Asian women with estrogen receptor–positive (ER+)/human epidermal growth factor receptor 2–negative (HER2-) metastatic breast cancer (mBC)
Im, S-A., Mukai, H., Park, I.H., Masuda, N., Shimizu, C., Kim, S.B., Im, Y-H., Ohtani, S., Bartlett, C.H., Lu, D.R., Mori, A., Gauthier, E., Finn, R.S., Toi, M.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw577
Date:
December, 2016
File:
PDF, 43 KB
english, 2016
File converter
More search results
More benefits 
